Evaluation of teicoplanin's therapeutic efficacy in immunocompromised patients with staphylococcal sepsis.
Orani
A
A
Infectious Diseases Dept. - Hospital of Lecco, Italy.
Fossati
M
M
Castelli
N
N
Sala
A
A
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005260:Female; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000276:immunology; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000276:immunology; D017334:Teicoplanin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D017334:Teicoplanin